End date of survey results used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without the return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information through a post market clinical follow-up survey on contegra pulmonary valved conduit.Observations that were stated as related to pre-existing patient condition included: one pulmonary hypertension, one pulmonary insufficiency, one infection, and one stenosis.Observations that were stated as related to the procedure but not directly to the contegra conduit included: one endocarditis, and one prosthesis calcification or stenosis.Observations that were stated as directly related to the conduit included: one device or packaging identification issues, and one obstruction of implant with clinical impact within 60 days requiring intervention to explant conduit.No serial numbers were provided.No additional adverse patient effects or product performance issues were reported.
|